⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AARD News
Aardvark Therapeutics, Inc. Common Stock
Pomerantz LLP Pursues Shareholder Class Action Against Aardvark Therapeutics, Inc. – AARD
accessnewswire.com
AARD
Aardvark Therapeutics, Inc. (AARD) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
prnewswire.com
AARD
AARD DEADLINE: Levi & Korsinsky Reminds Aardvark Therapeutics, Inc. Investors of Upcoming Securities Class Action Deadline
globenewswire.com
AARD
AARD INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aardvark Therapeutics, Inc. Investors Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
AARD
Aardvark Therapeutics, Inc. (AARD) Investors with Substantial Losses Have Opportunity to Lead Aardvark Class Action Lawsuit Before October 13 Deadline
prnewswire.com
AARD
AARD EQUITY ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Aardvark (AARD) Investors of Securities Class Action Lawsuit Deadline on October 13, 2026 Ready to Announce with Confidence?
newsfilecorp.com
AARD
Pomerantz LLP Initiates Class Action Litigation Against Aardvark Therapeutics, Inc. – AARD
accessnewswire.com
AARD
Aardvark Therapeutics, Inc. (AARD) Lawsuit - Investors Urged to Contact Levi & Korsinsky Before October 13, 2026
accessnewswire.com
AARD
Class Action Filed Against Aardvark Therapeutics, Inc. (AARD) Over Securities Violations - Contact Levi & Korsinsky Today
accessnewswire.com
AARD
Class Action Lawsuit Filed Against Aardvark Therapeutics, Inc. (AARD) - Recover Losses - Contact Levi & Korsinsky Before October 13, 2026
accessnewswire.com
AARD